top of page

Jupiter Life Line Hospitals: Key IPO Details

Sep 5, 2023
2 min read

Updated: Sep 13, 2023


Jupiter Hospital IPO

Basic information about the company Founded in 2007, Jupiter Life Line Hospitals Limited has emerged as a beacon of healthcare excellence in the Mumbai Metropolitan Area (MMR) and the western region of India. With a steadfast commitment to providing top-notch medical services, this multi-speciality tertiary and quaternary healthcare provider has carved a niche for itself in the healthcare industry. Jupiter Life Line Hospitals currently operates three state-of-the-art facilities under the "Jupiter" brand. These hospitals are strategically located in Thane, Pune, and Indore, ensuring comprehensive healthcare access to a wide geographical area. As of March 31, 2023, the combined bed capacity of these hospitals exceeds 1100, supported by a dedicated team of over 1,300 doctors, including specialists, physicians, and surgeons. Objectives of the Issue The company intends to utilize the net proceeds from the IPO for the following key objectives:

1. Repayment of Borrowings

Jupiter Life Line Hospitals plans to allocate a portion of the funds raised towards the repayment or pre-payment of borrowings availed from banks by the company and Material Subsidiary. This move not only reduces financial burdens but also strengthens their financial position. 2. General Corporate Purposes

In addition to debt repayment, the company will utilize the funds for general corporate purposes. This includes investing in infrastructure, technology upgrades, and enhancing the overall patient experience. By doing so, Jupiter Life Line Hospitals aims to fortify its position as a leader in healthcare services. Jupiter Life Line Hospitals: Key IPO Details

Dates: 6th to 8th Sept 2023

Price Band: ₹695 to ₹735 per share

Lot Size: 20 Shares

Issue Size: ₹869 Crores

Allotment Date: 13/14 Sept 2023

Listing Date: 18th Sept 2023

GMP: +20% (only for information) Link for checking IPO Allotment Status👇 https://kprism.kfintech.com/ipostatus/ 💰Join our WhatsApp Group for Trading/Investment ideas & Market Updates👇

DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor before making any actual investment decisions, based on the information published here. Any reader taking decisions based on any information published here does so entirely at their own risk. Investors should bear in mind that any investment in the stock market is subject to unpredictable market-related risks. The author has no plans to invest in this offer and also the author does not recommend investing in any offer published on this website.

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating


SEBI Registered Research Analyst Details:
Registered Name:
Aditya Umesh Hujband
SEBI Registration No.: INH000011185
Type of Registration: Individual 
Validity: Jan 03, 2023 - Jan 02, 2028
Registered Office Address: Haresh Niwas, Room No.487, B.K. No A-82, Near Mahan Apartment, Ulhasnagar, Maharashtra, 421001
Contact No.: +91 9594941559
Email: hujbandaditya@gmail.com

 

SEBI Office Details: SEBI Bhavan BKC, Address: Plot No.C4-A, 'G' Block Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra | Tel: +91-22-26449000 / 40459000 | Fax: +91-22-26449019-22 / 40459019-22
Email: sebi@sebi.gov.in 
Toll-Free Investor Helpline: 1800 22 7575 
SCORES: https://scores.sebi.gov.in/
SMARTODR: https://smartodr.in/login

Please Note:
Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, Enlistment with RAASB/BSE and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.


Disclaimer Link

Sitemap: https://www.mbainvestmentwala.com/sitemap

 

Accessibility Assistance: 

  • We are committed to making our website accessible and user-friendly for all visitors, including persons with disabilities, in line with applicable SEBI accessibility requirements.

  • If you experience any difficulty accessing any part of this website, encounter inaccessible content, or require information in an alternative format, please feel free to contact us. We will make reasonable efforts to provide the requested information and resolve the issue at the earliest. 

  • Accessibility Statement: Accessibility Statement Link

 Contact Details:

 1. Phone: +91 9594941599
2. Email: mbainvestmentwala@gmail.com
We sincerely apologise for any inconvenience caused.

 

Aditya Hujband
SEBI Registration No. INH000011185

  • MBA Investmentwala on Quora
  • MBA Investmentwala Whatsapp Link
  • alt.text.label.Instagram
  • alt.text.label.Twitter
bottom of page